USFDA Issues Warning Letter to Eugia Pharma for Manufacturing Violations
MM Desk
26 August, 2024
The US Food and Drug Administration (USFDA) has issued a warning to Aurobindo Pharma’s subsidiary,
The US Food and Drug Administration (USFDA) has issued a warning to Aurobindo Pharma’s subsidiary,
Eugia Pharma Specialities, a fully owned subsidiary of Aurobindo Pharma, has recently received a warning